Serial Number | 90266118 |
Word Mark | TEVA |
Filing Date | Tuesday, October 20, 2020 |
Status | 700 - REGISTERED |
Status Date | Tuesday, December 19, 2023 |
Registration Number | 7249759 |
Registration Date | Tuesday, December 19, 2023 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, March 16, 2021 |
Description of Mark | The mark consists of two curved band designs that begins at the bottom center of an outlined rectangle and rise up toward the upper right hand corner of the rectangle. In the center of the curved band design is a large circle with an outline around the left side. In the bottom right hand corner is the word ''TEVA'' in lower case letters. The ''V'' in the word ''TEVA'' is formed by 2 leaf shapes. The entire mark is outlined by a thin line in the shape of a rectangle. |
Goods and Services | Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system |
Translation of Words in Mark | The English translation of the word "TEVA" in the mark is "nature". |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, December 8, 2020 |
Primary Code | 005 |
First Use Anywhere Date | Friday, November 1, 2013 |
First Use In Commerce Date | Friday, November 1, 2013 |
Party Name | Teva Pharmaceutical Industries Ltd. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Tel Aviv 6944020 IL |
Party Name | Teva Pharmaceutical Industries Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Tel Aviv 6944020 IL |
Party Name | Teva Pharmaceutical Industries Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Jerusalem 91010 IL |
Event Date | Event Description |
Tuesday, December 19, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, December 19, 2023 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, November 14, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Monday, November 13, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Monday, November 13, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
Wednesday, November 8, 2023 | USE AMENDMENT FILED |
Wednesday, November 8, 2023 | TEAS STATEMENT OF USE RECEIVED |
Tuesday, May 2, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, April 28, 2023 | SOU EXTENSION 4 GRANTED |
Friday, April 28, 2023 | SOU EXTENSION 4 FILED |
Friday, April 28, 2023 | SOU TEAS EXTENSION RECEIVED |
Friday, November 4, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, November 2, 2022 | SOU EXTENSION 3 GRANTED |
Wednesday, November 2, 2022 | SOU EXTENSION 3 FILED |
Wednesday, November 2, 2022 | SOU TEAS EXTENSION RECEIVED |
Tuesday, May 17, 2022 | SOU EXTENSION 3 DENIAL LETTER PREPARED |
Tuesday, May 17, 2022 | SOU EXTENSION 3 DENIAL LETTER PREPARED |
Tuesday, May 17, 2022 | SOU EXTENSION 3 FILED |
Tuesday, May 17, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Tuesday, May 10, 2022 | SOU TEAS EXTENSION RECEIVED |
Wednesday, May 11, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, May 9, 2022 | SOU EXTENSION 2 GRANTED |
Monday, May 9, 2022 | SOU EXTENSION 2 FILED |
Monday, May 9, 2022 | SOU TEAS EXTENSION RECEIVED |
Tuesday, November 9, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, November 5, 2021 | SOU EXTENSION 1 GRANTED |
Friday, November 5, 2021 | SOU EXTENSION 1 FILED |
Friday, November 5, 2021 | SOU TEAS EXTENSION RECEIVED |
Tuesday, May 11, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, March 16, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, March 16, 2021 | PUBLISHED FOR OPPOSITION |
Wednesday, February 24, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, February 9, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, February 9, 2021 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, February 9, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, February 9, 2021 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, February 9, 2021 | EXAMINERS AMENDMENT -WRITTEN |
Friday, February 5, 2021 | ASSIGNED TO EXAMINER |
Wednesday, December 9, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Tuesday, December 8, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, October 23, 2020 | NEW APPLICATION ENTERED |